Pfizer and BioNTech have asked U.S. regulators to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11, potentially the first shot available to this age group.
Meanwhile, the U.S. academic year is underway as the Delta variant dominates outbreaks, leaving parents concerned about their children’s safety at school. Pediatric cases of COVID-19 surged and peaked in mid-September. The CDC has not found that the contagious Delta variant is more severe than previous variants.
Here’s a look at what the data can tell us about pediatric COVID-19: